argenx Management
Management criteria checks 2/4
argenx's CEO is Tim Van Hauwermeiren, appointed in Apr 2008, has a tenure of 16.25 years. total yearly compensation is $11.94M, comprised of 5.5% salary and 94.5% bonuses, including company stock and options. directly owns 0.024% of the company’s shares, worth €6.03M. The average tenure of the management team and the board of directors is 2.4 years and 7.3 years respectively.
Key information
Tim Van Hauwermeiren
Chief executive officer
US$11.9m
Total compensation
CEO salary percentage | 5.5% |
CEO tenure | 16.3yrs |
CEO ownership | 0.02% |
Management average tenure | 2.4yrs |
Board average tenure | 7.3yrs |
Recent management updates
Recent updates
argenx SE's (EBR:ARGX) Shares Climb 26% But Its Business Is Yet to Catch Up
Jun 26argenx SE's (EBR:ARGX) CEO Looks Like They Deserve Their Pay Packet
May 01Investors Appear Satisfied With argenx SE's (EBR:ARGX) Prospects
Apr 11Analyst Estimates: Here's What Brokers Think Of argenx SE (EBR:ARGX) After Its Yearly Report
Mar 24Analysts Have Made A Financial Statement On argenx SE's (EBR:ARGX) Full-Year Report
Mar 05argenx SE (EBR:ARGX) Shares Could Be 24% Below Their Intrinsic Value Estimate
Feb 23Getting In Cheap On argenx SE (EBR:ARGX) Is Unlikely
Dec 18Broker Revenue Forecasts For argenx SE (EBR:ARGX) Are Surging Higher
Jul 28An Intrinsic Calculation For argenx SE (EBR:ARGX) Suggests It's 31% Undervalued
Jul 17Revenues Tell The Story For argenx SE (EBR:ARGX)
Jun 20argenx (EBR:ARGX) Is Using Debt Safely
May 08We Think argenx (EBR:ARGX) Can Afford To Drive Business Growth
Apr 20Does argenx (EBR:ARGX) Have A Healthy Balance Sheet?
Dec 27CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Mar 31 2024 | n/a | n/a | -US$328m |
Dec 31 2023 | US$12m | US$656k | -US$295m |
Sep 30 2023 | n/a | n/a | -US$234m |
Jun 30 2023 | n/a | n/a | -US$397m |
Mar 31 2023 | n/a | n/a | -US$511m |
Dec 31 2022 | US$8m | US$639k | -US$710m |
Sep 30 2022 | n/a | n/a | -US$909m |
Jun 30 2022 | n/a | n/a | -US$907m |
Mar 31 2022 | n/a | n/a | -US$595m |
Dec 31 2021 | US$7m | US$652k | -US$408m |
Sep 30 2021 | n/a | n/a | -US$373m |
Jun 30 2021 | n/a | n/a | -US$319m |
Mar 31 2021 | n/a | n/a | -US$573m |
Dec 31 2020 | US$9m | US$641k | -US$608m |
Sep 30 2020 | n/a | n/a | -US$535m |
Jun 30 2020 | n/a | n/a | -US$359m |
Mar 31 2020 | n/a | n/a | -US$275m |
Dec 31 2019 | US$7m | US$589k | -US$181m |
Sep 30 2019 | n/a | n/a | -US$109m |
Jun 30 2019 | n/a | n/a | -US$104m |
Mar 31 2019 | n/a | n/a | -US$47m |
Dec 31 2018 | US$5m | US$573k | -US$76m |
Sep 30 2018 | n/a | n/a | -US$56m |
Jun 30 2018 | n/a | n/a | -US$47m |
Mar 31 2018 | n/a | n/a | -US$46m |
Dec 31 2017 | US$4m | US$365k | -US$34m |
Compensation vs Market: Tim's total compensation ($USD11.94M) is above average for companies of similar size in the Belgian market ($USD3.40M).
Compensation vs Earnings: Tim's compensation has increased whilst the company is unprofitable.
CEO
Tim Van Hauwermeiren (52 yo)
16.3yrs
Tenure
US$11,944,835
Compensation
Mr. Timothy Van Hauwermeiren, also known as Tim, MSc, EMBA, serves as Independent Non-Executive Director of Lexeo Therapeutics, Inc since July 2024. He has been Independent Director at iTeos Therapeutics,...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Executive Director | 16.3yrs | US$11.94m | 0.024% $ 6.0m | |
Chief Financial Officer | 3.1yrs | US$4.76m | 0.0050% $ 1.3m | |
Chief Operating Officer | 1.3yrs | US$7.65m | no data | |
VP & Global Head of Technical Operations | 2.3yrs | no data | no data | |
Chief Scientific Officer | 1.5yrs | no data | 0.00086% $ 220.6k | |
VP and Global Head of Corporate Communications & Investor Relations | 2.3yrs | no data | no data | |
General Counsel | 2.4yrs | no data | 0% $ 0 | |
Vice President of Corporate Development & Strategy | 5.1yrs | no data | 0.0021% $ 525.9k | |
Global Head of Human Resources | 5.6yrs | no data | no data | |
Global Head of Quality | 4.5yrs | no data | 0.00050% $ 128.3k | |
Chief Medical Officer | 2.3yrs | no data | 0.0027% $ 700.3k |
2.4yrs
Average Tenure
52yo
Average Age
Experienced Management: ARGX's management team is considered experienced (2.4 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Executive Director | 10yrs | US$11.94m | 0.024% $ 6.0m | |
Independent Vice-Chairman of the Board | 9.2yrs | US$482.23k | 0.00065% $ 166.7k | |
Independent Chairman of the Board | 10yrs | US$660.33k | 0.0023% $ 595.1k | |
Independent Non-Executive Director | 7.3yrs | US$476.82k | 0.00065% $ 166.7k | |
Independent Non-Executive Director | 6.2yrs | US$482.23k | 0.00065% $ 166.7k | |
Independent Non-Executive Director | 8.3yrs | US$471.41k | 0.00065% $ 166.7k | |
Member of Board Advisors | no data | no data | 0.62% $ 158.5m | |
Member of Board Advisors | no data | US$622.58k | no data | |
Independent Non-Executive Director | 1.4yrs | US$635.65k | 0.00022% $ 56.4k | |
Independent Non-Executive Director | 1.8yrs | US$365.24k | 0.00049% $ 125.7k | |
Member of Board Advisors | 1.3yrs | US$656.08k | 0.0055% $ 1.4m | |
Member of Board Advisors | no data | no data | no data |
7.3yrs
Average Tenure
63.5yo
Average Age
Experienced Board: ARGX's board of directors are considered experienced (7.3 years average tenure).